Linn Gillberg1,2, Alexander Perfilyev3, Charlotte Brøns4, Martin Thomasen4, Louise G Grunnet4, Petr Volkov3, Fredrik Rosqvist5, David Iggman5,6, Ingrid Dahlman7, Ulf Risérus5, Tina Rönn3, Emma Nilsson4,3, Allan Vaag4,8, Charlotte Ling9. 1. Department of Endocrinology, Rigshospitalet, Section 7652, Tagensvej 20, DK-2200, Copenhagen N, Denmark. linn.gillberg@rh.regionh.dk. 2. Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. linn.gillberg@rh.regionh.dk. 3. Epigenetics and Diabetes Unit, Department of Clinical Sciences, Lund University, Jan Waldenströms gata 35, SE-20502, Malmö, Sweden. 4. Department of Endocrinology, Rigshospitalet, Section 7652, Tagensvej 20, DK-2200, Copenhagen N, Denmark. 5. Clinical Nutrition and Metabolism, Department of Public Health and Caring Sciences, Uppsala University, Uppsala, Sweden. 6. Center for Clinical Research Dalarna, Falun, Sweden. 7. Department of Medicine, Karolinska Institutet, Huddinge, Stockholm, Sweden. 8. Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. 9. Epigenetics and Diabetes Unit, Department of Clinical Sciences, Lund University, Jan Waldenströms gata 35, SE-20502, Malmö, Sweden. charlotte.ling@med.lu.se.
Abstract
AIMS/HYPOTHESIS: Individuals who had a low birthweight (LBW) are at an increased risk of insulin resistance and type 2 diabetes when exposed to high-fat overfeeding (HFO). We studied genome-wide mRNA expression and DNA methylation in subcutaneous adipose tissue (SAT) after 5 days of HFO and after a control diet in 40 young men, of whom 16 had LBW. METHODS: mRNA expression was analysed using Affymetrix Human Gene 1.0 ST arrays and DNA methylation using Illumina 450K BeadChip arrays. RESULTS: We found differential DNA methylation at 53 sites in SAT from LBW vs normal birthweight (NBW) men (false discovery rate <5%), including sites in the FADS2 and CPLX1 genes previously associated with type 2 diabetes. When we used reference-free cell mixture adjustments to potentially adjust for cell composition, 4,323 sites had differential methylation in LBW vs NBW men. However, no differences in SAT gene expression levels were identified between LBW and NBW men. In the combined group of all 40 participants, 3,276 genes (16.5%) were differentially expressed in SAT after HFO (false discovery rate <5%) and there was no difference between LBW men and controls. The most strongly upregulated genes were ELOVL6, FADS2 and NNAT; in contrast, INSR, IRS2 and the SLC27A2 fatty acid transporter showed decreased expression after HFO. Interestingly, SLC27A2 expression correlated negatively with diabetes- and obesity-related traits in a replication cohort of 142 individuals. DNA methylation at 652 CpG sites (including in CDK5, IGFBP5 and SLC2A4) was altered in SAT after overfeeding in this and in another cohort. CONCLUSIONS/ INTERPRETATION: Young men who had a LBW exhibit epigenetic alterations in their adipose tissue that potentially influence insulin resistance and risk of type 2 diabetes. Short-term overfeeding influences gene transcription and, to some extent, DNA methylation in adipose tissue; there was no major difference in this response between LBW and control participants.
AIMS/HYPOTHESIS: Individuals who had a low birthweight (LBW) are at an increased risk of insulin resistance and type 2 diabetes when exposed to high-fat overfeeding (HFO). We studied genome-wide mRNA expression and DNA methylation in subcutaneous adipose tissue (SAT) after 5 days of HFO and after a control diet in 40 young men, of whom 16 had LBW. METHODS: mRNA expression was analysed using Affymetrix Human Gene 1.0 ST arrays and DNA methylation using Illumina 450K BeadChip arrays. RESULTS: We found differential DNA methylation at 53 sites in SAT from LBW vs normal birthweight (NBW) men (false discovery rate <5%), including sites in the FADS2 and CPLX1 genes previously associated with type 2 diabetes. When we used reference-free cell mixture adjustments to potentially adjust for cell composition, 4,323 sites had differential methylation in LBW vs NBW men. However, no differences in SAT gene expression levels were identified between LBW and NBW men. In the combined group of all 40 participants, 3,276 genes (16.5%) were differentially expressed in SAT after HFO (false discovery rate <5%) and there was no difference between LBW men and controls. The most strongly upregulated genes were ELOVL6, FADS2 and NNAT; in contrast, INSR, IRS2 and the SLC27A2 fatty acid transporter showed decreased expression after HFO. Interestingly, SLC27A2 expression correlated negatively with diabetes- and obesity-related traits in a replication cohort of 142 individuals. DNA methylation at 652 CpG sites (including in CDK5, IGFBP5 and SLC2A4) was altered in SAT after overfeeding in this and in another cohort. CONCLUSIONS/ INTERPRETATION: Young men who had a LBW exhibit epigenetic alterations in their adipose tissue that potentially influence insulin resistance and risk of type 2 diabetes. Short-term overfeeding influences gene transcription and, to some extent, DNA methylation in adipose tissue; there was no major difference in this response between LBW and control participants.
Authors: M Alligier; E Meugnier; C Debard; S Lambert-Porcheron; E Chanseaume; M Sothier; E Loizon; A Ait Hssain; J Brozek; J-Y Scoazec; B Morio; H Vidal; M Laville Journal: J Clin Endocrinol Metab Date: 2011-12-07 Impact factor: 5.958
Authors: Niclas Franck; Anders Gummesson; Margareta Jernås; Camilla Glad; Per-Arne Svensson; Gilles Guillot; Mats Rudemo; Fredrik H Nyström; Lena M S Carlsson; Bob Olsson Journal: J Clin Endocrinol Metab Date: 2010-11-03 Impact factor: 5.958
Authors: Charlotte Brøns; Stine Jacobsen; Emma Nilsson; Tina Rönn; Christine B Jensen; Heidi Storgaard; Pernille Poulsen; Leif Groop; Charlotte Ling; Arne Astrup; Allan Vaag Journal: J Clin Endocrinol Metab Date: 2010-04-21 Impact factor: 5.958
Authors: Stine C Jacobsen; Linn Gillberg; Jette Bork-Jensen; Rasmus Ribel-Madsen; Ester Lara; Vincenzo Calvanese; Charlotte Ling; Agustin F Fernandez; Mario F Fraga; Pernille Poulsen; Charlotte Brøns; Allan Vaag Journal: Diabetologia Date: 2014-02-26 Impact factor: 10.122
Authors: Yanping Li; Sylvia H Ley; Deirdre K Tobias; Stephanie E Chiuve; Tyler J VanderWeele; Janet W Rich-Edwards; Gary C Curhan; Walter C Willett; JoAnn E Manson; Frank B Hu; Lu Qi Journal: BMJ Date: 2015-07-21
Authors: D J Cuthbertson; T Steele; J P Wilding; J C Halford; J A Harrold; M Hamer; F Karpe Journal: Int J Obes (Lond) Date: 2017-01-12 Impact factor: 5.095
Authors: Rodrigo San-Cristobal; Santiago Navas-Carretero; Fermín I Milagro; J Ignacio Riezu-Boj; Elizabeth Guruceaga; Carlos Celis-Morales; Katherine M Livingstone; Lorraine Brennan; Julie A Lovegrove; Hannelore Daniel; Wim H Saris; Iwonna Traczyk; Yannis Manios; Eileen R Gibney; Michael J Gibney; John C Mathers; J Alfredo Martinez Journal: J Physiol Biochem Date: 2017-03-28 Impact factor: 4.158
Authors: Vanessa D de Mello; Ashok Matte; Alexander Perfilyev; Ville Männistö; Tina Rönn; Emma Nilsson; Pirjo Käkelä; Charlotte Ling; Jussi Pihlajamäki Journal: Epigenetics Date: 2017-02-23 Impact factor: 4.528